The new assay for MS signature autoantibodies may support MS diagnosis and provide a basis for a predictive risk score when integrated with other biomarkers.
Development of a diagnostic autoantibody assay to support multiple sclerosis diagnosis and risk prediction.
Absolute Event Rate: 0% vs 0%
We describe a test for MS signature autoantibodies that could be used to support MS diagnosis, prodromal research, and early interventions. The integration of this assay with other emerging biomarkers will advance progress toward a combined predictive risk score for MS.
McCutcheon et al. (Fri,) reported a other. The new assay for MS signature autoantibodies may support MS diagnosis and provide a basis for a predictive risk score when integrated with other biomarkers.